An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
BIMI Announces Results of 2023 Annual General Meeting of Stockholders
Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary
BIMI Holdings Inc. (NASDAQ: BIMI) announced the results of the 2022 Annual General Meeting of Stockholders, including the election of directors, changes to bylaws and certificate of incorporation, and ratification of the appointment of Enrome LLP as the independent registered public accounting firm.
Positive
None.
Negative
None.
New York, Jan. 03, 2024 (GLOBE NEWSWIRE) -- BIMI Holdings Inc. (NASDAQ: BIMI) (“BIMI” or the “Company”), previously known as (BIMI International Medical Inc.) a healthcare products and services provider, today announced the results of the Company’s 2022 Annual General Meeting of Stockholders (the “Annual Meeting”) held on Dec 29, 2023 at 11:00 a.m. at the offices of the Company, 725 5th Ave, New York, NY 10022.
At the Annual General Meeting the shareholders voted and approved;
1. The election of seven directors to serve on the board of directors of the Company, until the next annual meeting of Stockholders and until their respective successors have been duly elected and qualified;
2. The adoption of an amendment to the Company’s Amended and Restated Bylaws to change the Company’s staggered board (also known as classified board) to a standard board composition;
3. The adoption of an amendment to the Company’s Amended and Restated Certificate of Incorporation to change the Company’s name to BIMI Holdings Inc.;
4. On a non-binding advisory basis, the compensation of the Company’s executive officers;
5. On a non-binding advisory basis, annual non-binding advisory votes on resolutions approving named executive officer compensation (“Say When on Pay Vote”); and
6. Ratified the appointment of Enrome LLP as the Company’s independent registered public accounting firm for the year ended December 31, 2023.
About BIMI Holdings Inc. BIMI Holdings Inc. is a healthcare products and services provider, offering a broad range of healthcare products and related services in the U.S. and Asia. For more information, please visit usbimi.com.
Investor Relations Contact Investor Relations Department of BIMI International Medical Inc. Email: vinson@usbimi.com Tel: +1 949 981 6274
FAQ
What was approved at BIMI Holdings Inc.'s 2022 Annual General Meeting of Stockholders?
The approval included the election of directors, changes to bylaws and certificate of incorporation, and ratification of the appointment of Enrome LLP as the independent registered public accounting firm.
Where was the Annual General Meeting held?
The meeting was held at the offices of the Company, 725 5th Ave, New York, NY 10022.
What is the new name of BIMI Holdings Inc.?
The new name of the company is BIMI Holdings Inc.
What is the ticker symbol for BIMI Holdings Inc.?
The ticker symbol is NASDAQ: BIMI.
Who was ratified as the independent registered public accounting firm?
Enrome LLP was ratified as the Company’s independent registered public accounting firm for the year ended December 31, 2023.
bimi international medical inc. (nasdaq: bimi) is an american multinational healthcare products and services provider, offering a broad range of healthcare products and related services. the company currently operates in four segments: wholesale pharmaceuticals, wholesale medical devices, medical services and retail pharmacy. the wholesale pharmaceuticals segment includes supplying prescription and otc medicines, traditional chinese medicines (“tcm”), healthcare supplies and sundry items to clinics, third party pharmacies, hospitals and other drug wholesalers. the wholesale medical devices segment distributes medical devices, including medical consumables to private clinics, hospitals, third party pharmacies and other medical device dealers. medical services include private comprehensive hospitals operating in china. the retail pharmacy segment sells prescription and otc medicines, tcm, healthcare supplies and sundry items to retail customers through its directly-owned pharmacies a